Code | 6709E | ||||||||||
MA number | EU/1/22/1657/004 | ||||||||||
Product Form: | cps mdd 100x4 mg (fľ.HDPE) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU Orphan | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | bottle HDPE | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 15.07.2022 |
Validity: | 24.07.2029 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 06.08.2024 |